TS
PFE icon

Triglav Skladi’s Pfizer PFE Stock Holding History

Triglav Skladi’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.89M Sell
316,700
-99,092
-24% -$2.64M 0.62% 31
2025
Q4 		$10.4M Buy
415,792
+99,092
+31% +$2.5M 0.65% 35
2025
Q3 		$8.07M Hold
316,700
– – 0.53% 41
2025
Q2 		$7.68M Hold
316,700
– – 0.55% 36
2025
Q1 		$8.03M Hold
316,700
– – 0.67% 37
2024
Q4 		$8.4M Buy
+316,700
New +$8.59M 0.66% 35

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Triglav Skladi's PFE Position: Q1 2026 in Review

Triglav Skladi reduced its Pfizer (PFE) stake by 24% in Q1 2026, selling an estimated $2.64M and leaving 316,700 shares worth $8.89M. The position accounts for 0.62% of the portfolio, ranked #31.

Triglav Skladi first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.4M in Q4 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Triglav Skladi held 316,700 shares of Pfizer worth $8.89M as of Q1 2026.
  • Triglav Skladi sold 99,092 Pfizer shares in Q1 2026, an estimated $2.64M.
  • Pfizer made up 0.62% of Triglav Skladi's portfolio in Q1 2026, its #31 holding.
  • Triglav Skladi first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Pfizer position peaked at $10.4M in Q4 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.